Select Laboratories SC LLC

Select Laboratories SC LLC was paid $1.29M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 27% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in South Carolina

Rank by total paid#11 of 39

Median peer was paid$403K

This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	22,545	$176K
2019	18,111	$184K
2020	14,451	$219K
2021	13,698	$216K
2022	15,919	$276K
2023	10,006	$133K
2024incomplete	6,982	$81K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	27%	3,964	1,872	$348K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	13%	2,628	2,422	$171K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	5.7%	11,552	10,242	$73K
84443	Thyroid stimulating hormone (TSH)	5.6%	5,560	5,119	$72K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	5.3%	3,132	2,909	$68K
80053	Comprehensive metabolic panel	5.1%	8,265	7,605	$66K
80061	Lipid panel	5.0%	6,182	5,797	$64K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.1%	1,129	1,019	$53K
83036	Hemoglobin; glycosylated (A1C)	3.3%	5,353	4,889	$43K
80305		2.6%	4,494	2,738	$34K
87086	Culture, bacterial; quantitative colony count, urine	2.4%	4,487	3,787	$30K
80048	Basic metabolic panel (calcium, ionized)	1.7%	2,623	2,322	$22K

69 more codes

81025		1.4%	2,599	$17K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.2%	558	$16K
84439		1.2%	2,486	$16K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.2%	536	$15K
84153		1.2%	992	$15K
83721		1.1%	1,769	$14K
80164		1.0%	1,216	$13K
84481		<1%	858	$11K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	589	$11K
82607		<1%	853	$10K
87077		<1%	1,327	$10K
87186		<1%	910	$7K
80076		<1%	952	$7K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	934	$6K
82677		<1%	288	$6K
82746		<1%	436	$5K
84702		<1%	434	$4K
36415	Collection of venous blood by venipuncture	<1%	9,380	$4K
86336		<1%	302	$4K
83550		<1%	606	$4K
83735		<1%	750	$4K
87088		<1%	498	$3K
83540		<1%	719	$3K
82728		<1%	318	$3K
86762		<1%	290	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	98	$3K
87340		<1%	369	$3K
87070		<1%	382	$3K
86850		<1%	286	$3K
85660		<1%	470	$2K
82105		<1%	309	$2K
85027		<1%	395	$2K
80081		<1%	40	$2K
86803		<1%	156	$2K
86592		<1%	462	$2K
81001		<1%	548	$1K
81003		<1%	369	$742.51
86900		<1%	305	$722.84
86901		<1%	299	$705.45
83992		<1%	233	$298.18
80358		<1%	232	$254.37
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	962	$229.54
85651		<1%	64	$202.14
80346		<1%	237	$98.80
80356		<1%	239	$98.80
80361		<1%	237	$80.25
80363		<1%	237	$80.25
80355		<1%	237	$79.60
82043		<1%	16	$78.91
80323		<1%	239	$76.90
80325		<1%	238	$74.60
80345		<1%	237	$66.20
80373		<1%	237	$62.55
80337		<1%	237	$62.55
80372		<1%	237	$62.55
80348		<1%	237	$62.55
80369		<1%	237	$62.55
80354		<1%	237	$62.55
80334		<1%	237	$62.55
80365		<1%	237	$62.55
80366		<1%	237	$62.55
80367		<1%	237	$62.55
80368		<1%	237	$62.55
80359		<1%	239	$62.55
80350		<1%	239	$62.55
80349		<1%	239	$62.55
80371		<1%	239	$62.55
80353		<1%	239	$39.75
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	0%	45	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKNESEL, ERNEST (PRESIDENT)